Hyaluronic Acid API Market Size is valued at USD 501.85 Mn in 2023 and is predicted to reach USD 1,392.64 Mn by the year 2031 at a 13.77% CAGR during the forecast period for 2024-2031.
Hyaluronic acid, when used as an active pharmaceutical ingredient (API), is highly esteemed for its adaptability and effectiveness in addressing various conditions that necessitate lubrication and moisture preservation. This applies to both internal applications in joints and external applications on the skin and tissues. The biocompatibility and limited adverse effects of this substance continue to fuel its increasing use in novel therapeutic and cosmetic preparations. As a result of rising incomes and better healthcare infrastructure, hyaluronic acid API products are reaching more people in developing markets. The world’s aging population is expanding at a rapid pace. The body’s natural production of hyaluronic acid declines with age, causing wrinkles to appear and skin to lose its flexibility. Hyaluronic acid active pharmaceutical ingredient demand has skyrocketed due to the increasing popularity of skin care products and dermal fillers formulated with hyaluronic acid to stave off the appearance of aging for as long as possible.
However, market growth is hampered by the expensive hyaluronic acid API production costs and the availability of alternative medicine. Additionally, hyaluronic acid API market potential may arise as a result of healthcare amenity price increases. In addition, modern biotechnological developments have reduced production costs and increased the efficiency of hyaluronic acid synthesis. More and more people are learning about the importance of skincare and its advantages, which has boosted the demand for the hyaluronic acid API market.
Competitive Landscape
Some Major Key Players In The Hyaluronic Acid API Market:
- Bloomage Biotech
- Focus Chem
- Fufeng Group
- AWA Biopharm
- China Eastar Group
- Kewpie
- Seikagaku
- HTL Biotechnology
- Fidia Farmaceutici
- Other Market Players
Market Segmentation:
The hyaluronic acid API market is segmented based on type and application. Based on type, the market is segmented into animal tissue and microbial fermentation. As per the application segment, the market is segmented into cosmetics, medical and food.
Based On The Type, The Animal Tissue Segment Is Accounted As A Major Contributor To The Hyaluronic Acid API Market
The animal tissue hyaluronic acid API market is expected to lead with a major global market share in 2023 because of its efficacy and great biocompatibility. Animal tissue-derived hyaluronic acid, primarily from rooster combs and bovine vitreous humor, has a molecular structure that is very similar to naturally occurring human hyaluronic acid. This is very important for uses that require biocompatibility, like lip fillers, eye surgeries, and treatments to smooth out joints. Treatments are more effective, and side effects are less likely due to the resemblance, which helps reduce the body’s immune response factor, fueling the market’s expansion.
Cosmetics Segment To Witness Growth At A Rapid Rate
The cosmetics segment is growing rapidly because of its remarkable moisturizing characteristics, which aid in maintaining skin hydration and provide a full, young look. Hyaluronic acid is highly prized in the cosmetics business. An expanding number of cosmetics, including serums, moisturizers, foundations, and lip treatments, contain hyaluronic acid API as a key ingredient to combat the signs of aging and promote healthy skin. The market for cosmetics based on hyaluronic acid API has been further boosted by the growing awareness of the benefits of using clean, scientifically-backed skincare components.
In The Region, The North American Hyaluronic Acid API Market Holds A Significant Revenue Share.
The North American hyaluronic acid API market is expected to record the maximum market revenue share in the near future. Due to a rising focus on skincare and anti-aging products and a large concentration of well-known cosmetics and pharmaceutical brands. In addition, Europe is estimated to grow rapidly in the global hyaluronic acid API market because the availability of high-quality hyaluronic acid API is assured by the region’s strong regulatory framework for product approvals and safety regulations, an increase in the presence of key market competitors, and the rising cost of healthcare in the area.
Recent Developments:
- In Dec 2023, Bloomage unveiled its Bloomsurfact EncapCare RP emulsion solution. This solution effectively rejuvenates skin and fights against ageing. The EncapCare RP is a great alternative for sensitive skin because it uses Bloomage's proprietary component dispersion technology with Bloomsurfact Sodium Surfactin to guarantee high bioavailability, stability, and reduced irritation.
- In Oct 2021, HTL Biotechnology substantially enhanced its production capacity for hyaluronic acid through fermentation at its facility in Javené, France. According to HTL, their $58 million investment has positioned them as the leading global manufacturer of pharmaceutical-grade hyaluronic acid. Orthopedists employ hyaluronic acid injections to alleviate joint pain, while cosmetic surgeons utilize them to address sunken areas of the face, among other uses.
Hyaluronic Acid API Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 501.85 Mn |
|
Revenue Forecast In 2031 |
USD 1,392.64 Mn |
|
Growth Rate CAGR |
CAGR of 13.77% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Mn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Type And Application |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Bloomage Biotech, Focus Chem, Fufeng Group, AWA Biopharm, China Eastar Group, Kewpie, Seikagaku, HTL Biotechnology, Fidia Farmaceutici and Other market players. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
